Table 1.
Patient characteristics
| Characteristic | No. (%)a |
|---|---|
| N | 60 |
| Age, years (mean, range) | 74 (50–87) |
| Sex | |
| Female | 16 (27) |
| Male | 44 (73) |
| Cancer type | |
| Solid malignancies | |
| Colorectal | 14 (23) |
| Prostate | 8 (13) |
| Breast | 5 (8.3) |
| Melanoma | 4 (6.6) |
| Renal cell | 2 (3.3) |
| Oesophageal | 2 (3.3) |
| Brain | 2 (3.3) |
| Pancreatic | 1 (1.7) |
| Endometrium | 1 (1.7) |
| Lung | 1 (1.7) |
| Haematologic malignancies | |
| Myeloma | 9 (15) |
| Lymphoma | 6 (10) |
| Leukaemia | 3 (5.0) |
| Myelodysplastic syndrome | 2 (3.3) |
| Staging | |
| Solid malignancies staging | |
| I | 0 (0.0) |
| II | 0 (0.0) |
| III | 6 (10) |
| IV | 31 (52) |
| Not applicable | 2 (3.3) |
| Haematologic malignancies staging | 20 (33) |
| Unknown | 1 (1.7) |
| Number of drugs (mean, range) | |
| Total | 13 (6–23) |
| Oncology | 2 (0–6) |
| Oncology supportive | 2 (0–7) |
| Chronic | 9 (4–20) |
a
Data are depicted in frequencies and percentages, unless otherwise specified.